Multichromatic phenotyping of HER receptor coexpression in breast tumor tissue samples using flow cytometry--possibilities and limitations (Q39740378)

14 September 2017

Multichromatic phenotyping of HER receptor coexpression in breast tumor tissue samples using flow cytometry--possibilities and limitations (English)

1 reference

14 September 2017

1 reference

1 reference

Arabel Vollmann-Zwerenz

1

object named as

Arabel Vollmann-Zwerenz

1 reference

14 September 2017

Simone Diermeier-Daucher

2

object named as

Simone Diermeier-Daucher

1 reference

14 September 2017

9

Gero Brockhoff

1 reference

14 September 2017

Anja Kathrin Wege

3

1 reference

14 September 2017

Andrea Sassen

4

1 reference

14 September 2017

Elisabeth Schmidt-Brücken

5

1 reference

14 September 2017

Ferdinand Hofstaedter

6

1 reference

14 September 2017

Olaf Ortmann

7

1 reference

14 September 2017

Frans Nauwelaers

8

1 reference

14 September 2017

1 April 2010

1 reference

14 September 2017

1 reference

14 September 2017

77

1 reference

14 September 2017

4

1 reference

14 September 2017

387-398

1 reference

describes a project that uses

14 September 2017

1 reference

Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

HER2 oncogenic function escapes EGFR tyrosine kinase inhibitors via activation of alternative HER receptors in breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Presence of HER4 associates with increased sensitivity to Herceptin in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin-embedded breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

A chromatic explosion: the development and future of multiparameter flow cytometry.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Optimization of three- and four-color multiparameter DNA analysis in lymphoma specimens

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Use of a mechanical dissociation device to improve standardization of flow cytometric cytokeratin DNA measurements of colon carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

A practical approach to multicolor flow cytometry for immunophenotyping

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Role of ErbB4 in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

High-resolution multi-parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin-embedded tissues.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Simultaneous measurement of two cellular antigens and DNA using fluorescein-isothiocyanate, R-phycoerythrin, and propidium iodide on a standard FACScan.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

One-tube triple staining method for flow cytometric analysis of DNA ploidy and phenotypic heterogeneity of human solid tumors using single laser excitation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Improved single laser measurement of two cellular antigens and DNA-ploidy by the combined use of propidium iodide and TO-PRO-3 iodide

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Flow cytometric DNA and phenotype analysis in pathology. A meeting report of a symposium at the annual conference of the German Society of Pathology, Kiel, Germany, 6-9 June 2000.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Prognostic significance of the combination of biological parameters in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Cytomics in predictive medicine

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Multiparameter flow cytometric measurement of epidermal growth factor receptor and c-erbB-2 oncoprotein in cultured cells and in fresh and preserved solid tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20868

7 January 2021

Identifiers

DOI

10.1002/CYTO.A.20868

1 reference

14 September 2017

1 reference